NT-proBNP use in old patients and the impact of the selected threshold value: a big data analysis

Clin Chem Lab Med. 2021 Jul 2;59(12):e461-e464. doi: 10.1515/cclm-2021-0547. Print 2021 Nov 25.

Authors

François-Xavier Goudot¹, Tanissia Boukertouta¹, Adrian Lazureanu¹, Sonia MSadek¹, Edith Martins-Meune², Camille Chenevier-Gobeaux³, Christophe Meune¹

Affiliations

¹ Cardiology Department, Avicenne University Hospital, APHP, Université Sorbonne Paris Nord, Bobigny, France.
² Gerontology Department, Hôpital Max Fourestier, Nanterre, France.
³ Automated Biological Diagnosis Department, Cochin University Hospital, APHP.Centre - Université de Paris, Paris, France.

PMID: 34214333
DOI: 10.1515/cclm-2021-0547

No abstract available

Keywords: N terminal pro-brain natriuretic peptide (NT-proBNP); big data; natriuretic peptide; routine use.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Big Data
Biomarkers
Data Analysis*
Humans
Natriuretic Peptide, Brain*
Peptide Fragments
Prognosis

Substances

Biomarkers
Peptide Fragments
pro-brain natriuretic peptide (1-76)
Natriuretic Peptide, Brain